Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-COV03 in Dengue and Dengue-like Illness Patients
NCT07576868Phase 3Recruiting
- Sponsor
- Hyundai Bioscience
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niclosamide in dengue fever, Zika virus infection, influenza, coronavirus disease 2019 (COVID-19), sponsored by Hyundai Bioscience. Started Apr 2026; status: recruiting.
02
Drugs
niclosamide
03
Conditions
dengue feverZika virus infectioninfluenzacoronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07576868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07576868.